Particle engineering enhances drug solubility, bioavailability, and manufacturability. CDMOs like Evonik offer integrated expertise
Bringing an API to market has never been more demanding – development timelines are
Join Evonik at CPHI Frankfurt, Oct 28–30, to explore drug delivery technologies, CDMO services, and sustainable health care solutions. Visit booth #5.1A24 to connect with our experts and discover what’s next in pharma.
Particle engineering enhances drug solubility, bioavailability, and manufacturability. CDMOs like Evonik offer integrated expertise in crystallization, solid-state analysis, and process optimization, making them vital partners in pharmaceutical API
Evonik is building a pilot plant in Marl, Germany, for the production of its innovative and high-performance anion exchange membrane (AEM). Developed by Evonik the membrane is marketed under the name DURAION®.
